Gene and Cell Therapies for Diabetes Mellitus: Strategies and Clinical Potential.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 149, doi. 10.2165/00063030-200216030-00001
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2002 AND VI 16 AND IP 3
Results: 10
1
2
Gastric Inhibitory Polypeptide Analogues: Do They Have a Therapeutic Role in Diabetes Mellitus Similar to That of Glucagon-Like Peptide-1?
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 175, doi. 10.2165/00063030-200216030-00002
- By:
- Publication type:
- Article
3
Therapeutic Approaches in Multiple Sclerosis: Lessons from Failed and Interrupted Treatment Trials.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 183, doi. 10.2165/00063030-200216030-00003
- By:
- Publication type:
- Article
4
Waldenström's Macroglobulinaemia: Current Therapy and Future Approaches.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 201
- By:
- Publication type:
- Article
5
CellControl AG.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 209, doi. 10.2165/00063030-200216030-00005
- By:
- Publication type:
- Article
6
Spotlight on Peginterferon-α-2a (40KD) in Chronic Hepatitis C.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 213, doi. 10.2165/00063030-200216030-00006
- By:
- Publication type:
- Article
7
Profile Summary.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 219, doi. 10.2165/00063030-200216030-00007
- Publication type:
- Article
8
Exendin 4: AC 2993, AC 2993 LAR.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 220
- Publication type:
- Article
9
Human Haemoglobin - Hemosol: Hemolink.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 223, doi. 10.2165/00063030-200216030-00009
- Publication type:
- Article
10
Prostate Cancer Vaccine - Northwest Biotherapeutics: CaPVax, DC1/HRPC, DCVax - Prostate.
- Published in:
- BioDrugs, 2002, v. 16, n. 3, p. 226, doi. 10.2165/00063030-200216030-00010
- Publication type:
- Article